| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vibrio cholerae | 47 | 2024 | 98 | 9.170 |
Why?
|
| Francisella tularensis | 36 | 2017 | 115 | 6.140 |
Why?
|
| Bacterial Proteins | 50 | 2023 | 520 | 5.860 |
Why?
|
| Gene Expression Regulation, Bacterial | 33 | 2023 | 145 | 4.560 |
Why?
|
| Flagella | 13 | 2023 | 29 | 3.540 |
Why?
|
| Tularemia | 28 | 2016 | 114 | 3.430 |
Why?
|
| Vibrio | 8 | 2023 | 16 | 2.550 |
Why?
|
| Transcription Factors | 17 | 2014 | 653 | 2.260 |
Why?
|
| Virulence Factors | 12 | 2018 | 113 | 2.190 |
Why?
|
| DNA-Binding Proteins | 17 | 2007 | 522 | 1.870 |
Why?
|
| Cholera | 15 | 2024 | 70 | 1.840 |
Why?
|
| Virulence | 33 | 2023 | 221 | 1.790 |
Why?
|
| Francisella | 6 | 2016 | 19 | 1.630 |
Why?
|
| Transcription, Genetic | 16 | 2011 | 550 | 1.370 |
Why?
|
| Bacterial Outer Membrane Proteins | 10 | 2014 | 50 | 1.360 |
Why?
|
| Bacterial Vaccines | 14 | 2016 | 122 | 1.310 |
Why?
|
| Mutagenesis, Insertional | 5 | 2009 | 32 | 1.270 |
Why?
|
| Flagellin | 8 | 2018 | 16 | 1.230 |
Why?
|
| Cloning, Molecular | 4 | 2021 | 310 | 1.200 |
Why?
|
| Mice | 51 | 2023 | 5668 | 1.170 |
Why?
|
| Macrophages | 17 | 2014 | 431 | 1.170 |
Why?
|
| Animals | 64 | 2024 | 14307 | 0.960 |
Why?
|
| Diatoms | 1 | 2023 | 7 | 0.960 |
Why?
|
| Genetic Vectors | 4 | 2021 | 154 | 0.950 |
Why?
|
| Biofilms | 10 | 2019 | 166 | 0.900 |
Why?
|
| Vibrio cholerae O1 | 2 | 2021 | 11 | 0.880 |
Why?
|
| Molecular Sequence Data | 22 | 2014 | 1490 | 0.870 |
Why?
|
| Sigma Factor | 6 | 2004 | 17 | 0.870 |
Why?
|
| Intestines | 12 | 2023 | 63 | 0.860 |
Why?
|
| Genomic Islands | 7 | 2009 | 14 | 0.830 |
Why?
|
| Gram-Negative Bacteria | 2 | 2021 | 22 | 0.820 |
Why?
|
| Transformation, Bacterial | 1 | 2021 | 11 | 0.810 |
Why?
|
| DNA, Bacterial | 6 | 2009 | 184 | 0.810 |
Why?
|
| Phagosomes | 8 | 2010 | 30 | 0.810 |
Why?
|
| Adhesins, Bacterial | 7 | 2024 | 18 | 0.800 |
Why?
|
| Lipoproteins | 2 | 2014 | 61 | 0.790 |
Why?
|
| Interferon-gamma | 10 | 2016 | 235 | 0.730 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 59 | 0.730 |
Why?
|
| Trans-Activators | 6 | 2007 | 167 | 0.730 |
Why?
|
| DNA-Directed RNA Polymerases | 6 | 2010 | 25 | 0.720 |
Why?
|
| Fimbriae Proteins | 3 | 2008 | 18 | 0.710 |
Why?
|
| Vaccination | 4 | 2017 | 259 | 0.690 |
Why?
|
| Mice, Inbred BALB C | 20 | 2016 | 649 | 0.680 |
Why?
|
| Introns | 2 | 2009 | 67 | 0.670 |
Why?
|
| Bile | 7 | 2011 | 10 | 0.670 |
Why?
|
| Gene Targeting | 2 | 2008 | 39 | 0.640 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 22 | 0.630 |
Why?
|
| Gram-Negative Bacterial Infections | 3 | 2016 | 21 | 0.600 |
Why?
|
| Polymerase Chain Reaction | 5 | 2007 | 430 | 0.560 |
Why?
|
| Cholera Toxin | 4 | 2014 | 34 | 0.560 |
Why?
|
| Plasmids | 8 | 2021 | 233 | 0.540 |
Why?
|
| Genes, Bacterial | 9 | 2014 | 88 | 0.530 |
Why?
|
| Cyclic GMP | 3 | 2019 | 44 | 0.520 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2014 | 49 | 0.510 |
Why?
|
| Immunodominant Epitopes | 1 | 2014 | 27 | 0.510 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 29 | 0.510 |
Why?
|
| Porins | 4 | 2003 | 18 | 0.510 |
Why?
|
| Vaccines, Attenuated | 9 | 2016 | 72 | 0.510 |
Why?
|
| Base Sequence | 11 | 2014 | 932 | 0.500 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 40 | 0.490 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 55 | 0.490 |
Why?
|
| Humans | 47 | 2024 | 34853 | 0.470 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 187 | 0.470 |
Why?
|
| Quality of Health Care | 1 | 2014 | 136 | 0.460 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 162 | 0.450 |
Why?
|
| Promoter Regions, Genetic | 10 | 2018 | 484 | 0.440 |
Why?
|
| Fimbriae, Bacterial | 4 | 2008 | 22 | 0.440 |
Why?
|
| Bacterial Adhesion | 5 | 2018 | 36 | 0.440 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 1300 | 0.430 |
Why?
|
| Rats, Inbred F344 | 5 | 2017 | 228 | 0.420 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 115 | 0.410 |
Why?
|
| Naphthalimides | 1 | 2011 | 3 | 0.410 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2007 | 168 | 0.410 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2011 | 18 | 0.410 |
Why?
|
| Amino Acid Sequence | 9 | 2018 | 1124 | 0.410 |
Why?
|
| Quality of Life | 2 | 2017 | 459 | 0.400 |
Why?
|
| Butyrates | 1 | 2011 | 31 | 0.400 |
Why?
|
| Transcriptional Activation | 6 | 2007 | 164 | 0.400 |
Why?
|
| Genetic Engineering | 2 | 2009 | 31 | 0.400 |
Why?
|
| Tryptophan | 1 | 2011 | 62 | 0.390 |
Why?
|
| Protein Multimerization | 1 | 2011 | 97 | 0.380 |
Why?
|
| Polysaccharides, Bacterial | 3 | 2010 | 12 | 0.360 |
Why?
|
| Gene Deletion | 6 | 2018 | 156 | 0.360 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 88 | 0.350 |
Why?
|
| Salmonella typhimurium | 7 | 2001 | 40 | 0.350 |
Why?
|
| Signal Transduction | 7 | 2019 | 1802 | 0.350 |
Why?
|
| Escherichia coli | 5 | 2021 | 436 | 0.330 |
Why?
|
| Mutation | 14 | 2009 | 1023 | 0.330 |
Why?
|
| Water Microbiology | 2 | 2014 | 72 | 0.330 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2005 | 60 | 0.320 |
Why?
|
| Repressor Proteins | 1 | 2009 | 226 | 0.310 |
Why?
|
| Lipopolysaccharides | 6 | 2011 | 200 | 0.310 |
Why?
|
| Alanine | 1 | 2007 | 28 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 11 | 2018 | 1530 | 0.300 |
Why?
|
| Models, Animal | 3 | 2017 | 131 | 0.300 |
Why?
|
| Antibodies, Bacterial | 6 | 2014 | 107 | 0.290 |
Why?
|
| Dipeptides | 1 | 2006 | 29 | 0.280 |
Why?
|
| Protein Binding | 5 | 2014 | 913 | 0.280 |
Why?
|
| beta-Galactosidase | 4 | 2007 | 34 | 0.280 |
Why?
|
| Mast Cells | 3 | 2012 | 77 | 0.280 |
Why?
|
| Peptides, Cyclic | 1 | 2006 | 30 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2009 | 486 | 0.280 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2005 | 7 | 0.270 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2018 | 16 | 0.270 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 106 | 0.260 |
Why?
|
| Alkaline Phosphatase | 3 | 2012 | 48 | 0.260 |
Why?
|
| Vibrio cholerae O139 | 1 | 2004 | 1 | 0.260 |
Why?
|
| Amoeba | 1 | 2004 | 6 | 0.250 |
Why?
|
| Toxins, Biological | 1 | 2024 | 3 | 0.250 |
Why?
|
| Sodium | 1 | 2004 | 101 | 0.250 |
Why?
|
| Intestine, Small | 2 | 2001 | 24 | 0.240 |
Why?
|
| Lung | 6 | 2010 | 413 | 0.240 |
Why?
|
| Oncorhynchus mykiss | 1 | 2023 | 2 | 0.240 |
Why?
|
| Cell Aggregation | 1 | 2023 | 14 | 0.240 |
Why?
|
| Amino Acid Substitution | 3 | 2011 | 122 | 0.240 |
Why?
|
| Alleles | 2 | 2021 | 284 | 0.240 |
Why?
|
| Mycobacterium marinum | 1 | 2003 | 7 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 298 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 383 | 0.230 |
Why?
|
| RNA Polymerase Sigma 54 | 5 | 2001 | 5 | 0.220 |
Why?
|
| Female | 20 | 2018 | 19873 | 0.220 |
Why?
|
| Mutation, Missense | 2 | 2014 | 80 | 0.220 |
Why?
|
| Zebrafish | 1 | 2003 | 118 | 0.220 |
Why?
|
| Models, Molecular | 5 | 2018 | 751 | 0.210 |
Why?
|
| Interleukin-4 | 3 | 2012 | 69 | 0.200 |
Why?
|
| Movement | 4 | 2004 | 86 | 0.200 |
Why?
|
| Vibrio Infections | 2 | 2014 | 4 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 968 | 0.200 |
Why?
|
| Chitin | 1 | 2021 | 19 | 0.200 |
Why?
|
| Infant | 2 | 2023 | 1014 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 3 | 2012 | 179 | 0.200 |
Why?
|
| Bacteria | 2 | 2023 | 245 | 0.190 |
Why?
|
| Colony Count, Microbial | 4 | 2009 | 66 | 0.190 |
Why?
|
| Antigens, Bacterial | 3 | 2009 | 129 | 0.190 |
Why?
|
| Animals, Suckling | 3 | 2009 | 10 | 0.190 |
Why?
|
| Temperature | 3 | 2014 | 275 | 0.190 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 34 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 455 | 0.190 |
Why?
|
| Cell Line | 6 | 2014 | 1289 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 600 | 0.180 |
Why?
|
| Proteomics | 3 | 2007 | 302 | 0.180 |
Why?
|
| Lipid A | 2 | 2011 | 7 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 251 | 0.170 |
Why?
|
| Multigene Family | 3 | 2010 | 105 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2018 | 44 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Thioredoxins | 1 | 2018 | 43 | 0.160 |
Why?
|
| Acinetobacter baumannii | 1 | 2018 | 33 | 0.160 |
Why?
|
| Cytoskeleton | 1 | 2018 | 98 | 0.160 |
Why?
|
| Glutamine | 2 | 2000 | 31 | 0.160 |
Why?
|
| Lymphedema | 1 | 2017 | 4 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2010 | 286 | 0.160 |
Why?
|
| Protein Transport | 3 | 2012 | 286 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 249 | 0.160 |
Why?
|
| Cost of Illness | 1 | 2017 | 79 | 0.150 |
Why?
|
| Protein Conformation | 1 | 2018 | 350 | 0.150 |
Why?
|
| Escherichia coli Proteins | 2 | 2012 | 119 | 0.140 |
Why?
|
| Dimerization | 2 | 2007 | 102 | 0.140 |
Why?
|
| Disease Susceptibility | 2 | 2010 | 92 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 52 | 0.130 |
Why?
|
| Survival Analysis | 6 | 2018 | 322 | 0.130 |
Why?
|
| Spleen | 6 | 2016 | 192 | 0.130 |
Why?
|
| Glutamate-Ammonia Ligase | 3 | 2000 | 10 | 0.130 |
Why?
|
| Immunization | 2 | 2012 | 90 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 61 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2005 | 132 | 0.130 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.130 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 14 | 0.130 |
Why?
|
| Base Pairing | 1 | 2014 | 42 | 0.130 |
Why?
|
| Models, Biological | 3 | 2007 | 642 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2014 | 48 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 92 | 0.120 |
Why?
|
| Rats | 3 | 2017 | 3261 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2008 | 257 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 57 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 123 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 1 | 2014 | 142 | 0.120 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2013 | 6 | 0.120 |
Why?
|
| Binding Sites | 2 | 2005 | 597 | 0.120 |
Why?
|
| Operon | 2 | 2007 | 43 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 180 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2011 | 135 | 0.120 |
Why?
|
| Cells, Cultured | 7 | 2012 | 1442 | 0.110 |
Why?
|
| Heme | 1 | 2013 | 69 | 0.110 |
Why?
|
| Microbial Viability | 2 | 2009 | 35 | 0.110 |
Why?
|
| Phosphorus-Oxygen Lyases | 1 | 2012 | 5 | 0.110 |
Why?
|
| Hemerythrin | 1 | 2012 | 50 | 0.110 |
Why?
|
| Cytoplasm | 2 | 2005 | 135 | 0.110 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2012 | 45 | 0.110 |
Why?
|
| Perforin | 1 | 2012 | 9 | 0.110 |
Why?
|
| Bacteremia | 1 | 2012 | 31 | 0.110 |
Why?
|
| Open Reading Frames | 2 | 2010 | 73 | 0.110 |
Why?
|
| Granzymes | 1 | 2012 | 16 | 0.110 |
Why?
|
| Gene Expression | 3 | 2008 | 639 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 25 | 0.110 |
Why?
|
| DNA Transposable Elements | 2 | 2003 | 44 | 0.110 |
Why?
|
| Iron | 1 | 2013 | 204 | 0.100 |
Why?
|
| Acyltransferases | 1 | 2011 | 21 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2011 | 78 | 0.100 |
Why?
|
| Mannose | 1 | 2011 | 25 | 0.100 |
Why?
|
| Oligosaccharides | 1 | 2011 | 24 | 0.100 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2010 | 10 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2011 | 360 | 0.100 |
Why?
|
| HLA-DR4 Antigen | 1 | 2009 | 20 | 0.090 |
Why?
|
| Hemagglutination | 1 | 2009 | 3 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2000 | 878 | 0.090 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2009 | 10 | 0.090 |
Why?
|
| Hemagglutinins | 1 | 2009 | 8 | 0.090 |
Why?
|
| Transcription Initiation Site | 2 | 2009 | 12 | 0.090 |
Why?
|
| Hemolysis | 1 | 2009 | 39 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 485 | 0.090 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2009 | 1 | 0.090 |
Why?
|
| Vibrio cholerae non-O1 | 1 | 2009 | 2 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 57 | 0.090 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 58 | 0.090 |
Why?
|
| NAD | 1 | 2009 | 39 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2009 | 107 | 0.080 |
Why?
|
| Contact Inhibition | 1 | 2008 | 4 | 0.080 |
Why?
|
| Acid Phosphatase | 1 | 2008 | 19 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 143 | 0.080 |
Why?
|
| Cell Division | 2 | 2000 | 296 | 0.080 |
Why?
|
| Spain | 1 | 2008 | 33 | 0.080 |
Why?
|
| beta-Lactamases | 1 | 2008 | 33 | 0.080 |
Why?
|
| Administration, Oral | 4 | 2012 | 212 | 0.080 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2008 | 108 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2012 | 897 | 0.080 |
Why?
|
| Isoelectric Focusing | 1 | 2007 | 16 | 0.080 |
Why?
|
| Kinetics | 4 | 2009 | 650 | 0.080 |
Why?
|
| Regulon | 1 | 2007 | 2 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 26 | 0.080 |
Why?
|
| Administration, Intranasal | 4 | 2009 | 77 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 79 | 0.080 |
Why?
|
| DNA Replication | 1 | 2008 | 148 | 0.080 |
Why?
|
| PII Nitrogen Regulatory Proteins | 4 | 1994 | 4 | 0.080 |
Why?
|
| Lac Operon | 1 | 2007 | 19 | 0.080 |
Why?
|
| Cytosol | 1 | 2007 | 85 | 0.080 |
Why?
|
| DNA Primers | 1 | 2007 | 269 | 0.080 |
Why?
|
| Aspartic Acid | 2 | 2000 | 46 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 341 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2007 | 87 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2006 | 44 | 0.070 |
Why?
|
| Environmental Microbiology | 3 | 2014 | 26 | 0.070 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2006 | 4 | 0.070 |
Why?
|
| Gene Order | 2 | 2008 | 15 | 0.070 |
Why?
|
| Gene Fusion | 1 | 2005 | 6 | 0.070 |
Why?
|
| Luciferases | 1 | 2005 | 62 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 89 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 36 | 0.070 |
Why?
|
| Cholera Vaccines | 2 | 2002 | 18 | 0.070 |
Why?
|
| Artificial Gene Fusion | 1 | 2005 | 4 | 0.070 |
Why?
|
| DNA Footprinting | 1 | 2005 | 9 | 0.070 |
Why?
|
| Sepsis | 2 | 2018 | 76 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2005 | 6 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 120 | 0.070 |
Why?
|
| Phenotype | 2 | 2001 | 650 | 0.070 |
Why?
|
| Neutropenia | 1 | 2005 | 18 | 0.070 |
Why?
|
| Interleukin-12 | 1 | 2004 | 46 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2009 | 323 | 0.060 |
Why?
|
| Escherichia coli Infections | 1 | 2005 | 39 | 0.060 |
Why?
|
| Leukemia | 1 | 2005 | 54 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 407 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 62 | 0.060 |
Why?
|
| Fucose | 1 | 2024 | 4 | 0.060 |
Why?
|
| Ampicillin Resistance | 1 | 2003 | 3 | 0.060 |
Why?
|
| Recombinases | 1 | 2003 | 3 | 0.060 |
Why?
|
| Host-Parasite Interactions | 1 | 2004 | 43 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 106 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2003 | 18 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2008 | 834 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2023 | 6 | 0.060 |
Why?
|
| Acclimatization | 1 | 2023 | 20 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2024 | 55 | 0.060 |
Why?
|
| Climate Change | 1 | 2023 | 33 | 0.060 |
Why?
|
| Mammals | 1 | 2024 | 96 | 0.060 |
Why?
|
| Vaccines | 1 | 2003 | 49 | 0.060 |
Why?
|
| Bacterial Capsules | 1 | 2002 | 6 | 0.060 |
Why?
|
| Ion Channels | 1 | 2003 | 69 | 0.060 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2001 | 3 | 0.050 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2001 | 7 | 0.050 |
Why?
|
| Polymyxin B | 2 | 2011 | 7 | 0.050 |
Why?
|
| Detergents | 1 | 2001 | 23 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2001 | 7 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 117 | 0.050 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2001 | 1 | 0.050 |
Why?
|
| UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 2001 | 11 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2001 | 87 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 155 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2001 | 57 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2000 | 20 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2000 | 32 | 0.050 |
Why?
|
| Genes, MHC Class I | 2 | 2012 | 13 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2012 | 423 | 0.050 |
Why?
|
| Genes, MHC Class II | 2 | 2012 | 20 | 0.050 |
Why?
|
| Cell Death | 2 | 2012 | 260 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2000 | 21 | 0.050 |
Why?
|
| Hemolysin Proteins | 1 | 2000 | 3 | 0.050 |
Why?
|
| Middle Aged | 5 | 2018 | 9642 | 0.050 |
Why?
|
| Bacteriophages | 1 | 2000 | 43 | 0.050 |
Why?
|
| Photobacterium | 1 | 2000 | 5 | 0.050 |
Why?
|
| Phosphates | 1 | 2000 | 49 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2000 | 35 | 0.050 |
Why?
|
| Species Specificity | 2 | 2012 | 233 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2011 | 355 | 0.040 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 13 | 0.040 |
Why?
|
| Adult | 5 | 2018 | 11034 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 25 | 0.040 |
Why?
|
| Symbiosis | 2 | 2010 | 42 | 0.040 |
Why?
|
| Software | 1 | 2000 | 204 | 0.040 |
Why?
|
| Pressure | 1 | 2018 | 36 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1998 | 84 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 186 | 0.040 |
Why?
|
| Inservice Training | 1 | 2018 | 30 | 0.040 |
Why?
|
| Germany | 1 | 2017 | 21 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 224 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 159 | 0.040 |
Why?
|
| O Antigens | 2 | 2011 | 5 | 0.040 |
Why?
|
| Adoptive Transfer | 2 | 2008 | 48 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2010 | 24 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2008 | 185 | 0.040 |
Why?
|
| Aged | 4 | 2017 | 6448 | 0.040 |
Why?
|
| Genome, Bacterial | 2 | 2009 | 114 | 0.040 |
Why?
|
| Genetic Complementation Test | 2 | 2011 | 56 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2011 | 255 | 0.040 |
Why?
|
| Phylogeny | 1 | 2000 | 612 | 0.040 |
Why?
|
| Biological Transport | 1 | 1997 | 175 | 0.040 |
Why?
|
| Computational Biology | 2 | 2009 | 275 | 0.040 |
Why?
|
| HT29 Cells | 2 | 2006 | 40 | 0.040 |
Why?
|
| Nitrogen | 1 | 1997 | 63 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 1993 | 172 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2016 | 54 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 51 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Liver | 2 | 2008 | 447 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1994 | 25 | 0.030 |
Why?
|
| Ureteral Calculi | 1 | 1974 | 3 | 0.030 |
Why?
|
| Incidence | 2 | 2009 | 882 | 0.030 |
Why?
|
| Male | 4 | 2018 | 18870 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1349 | 0.030 |
Why?
|
| Eubacterium | 1 | 1993 | 1 | 0.030 |
Why?
|
| Glutamates | 1 | 1993 | 21 | 0.030 |
Why?
|
| Polymers | 1 | 1994 | 117 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 52 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 97 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2005 | 203 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 13 | 0.030 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 2012 | 8 | 0.030 |
Why?
|
| Chaperonin 60 | 1 | 2012 | 15 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2012 | 94 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 45 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2012 | 161 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1994 | 287 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1993 | 154 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 47 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 376 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2012 | 96 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 58 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 129 | 0.030 |
Why?
|
| Nitrites | 1 | 2011 | 38 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1991 | 78 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 150 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 48 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Mannose-Binding Lectins | 1 | 2010 | 14 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 2333 | 0.020 |
Why?
|
| Organelles | 1 | 2010 | 23 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 31 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 66 | 0.020 |
Why?
|
| Gentamicins | 2 | 2004 | 9 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 35 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 298 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2561 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2010 | 97 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 135 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 194 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2009 | 143 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 170 | 0.020 |
Why?
|
| IgA Deficiency | 1 | 2009 | 6 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 61 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2009 | 32 | 0.020 |
Why?
|
| India | 1 | 2009 | 82 | 0.020 |
Why?
|
| Endosomes | 1 | 2008 | 34 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 249 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2008 | 35 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 396 | 0.020 |
Why?
|
| Diarrhea | 1 | 2009 | 84 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2008 | 48 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 143 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2008 | 68 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 605 | 0.020 |
Why?
|
| Silver Staining | 1 | 2007 | 7 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 608 | 0.020 |
Why?
|
| Superinfection | 1 | 2007 | 2 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 209 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 310 | 0.020 |
Why?
|
| Organisms, Genetically Modified | 1 | 2006 | 5 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 404 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 347 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 445 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2006 | 59 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 5035 | 0.020 |
Why?
|
| Pneumonia, Bacterial | 1 | 2006 | 21 | 0.020 |
Why?
|
| Proteome | 1 | 2007 | 132 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2006 | 87 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 871 | 0.020 |
Why?
|
| Biodiversity | 1 | 2006 | 81 | 0.020 |
Why?
|
| Hospitalization | 1 | 2009 | 370 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2005 | 15 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2005 | 52 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2005 | 7 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2005 | 15 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2005 | 116 | 0.020 |
Why?
|
| Base Composition | 1 | 2004 | 22 | 0.020 |
Why?
|
| Lysosomes | 1 | 2005 | 80 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2009 | 1318 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2004 | 64 | 0.020 |
Why?
|
| Acanthamoeba | 1 | 2003 | 5 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2003 | 18 | 0.020 |
Why?
|
| Ion Transport | 1 | 2003 | 15 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2003 | 130 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1152 | 0.010 |
Why?
|
| Cephaloridine | 1 | 2002 | 1 | 0.010 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2001 | 3 | 0.010 |
Why?
|
| Galactose | 1 | 2001 | 7 | 0.010 |
Why?
|
| Child | 1 | 2009 | 2875 | 0.010 |
Why?
|
| Serotyping | 1 | 2000 | 36 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 20 | 0.010 |
Why?
|
| Adsorption | 1 | 2000 | 67 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 210 | 0.010 |
Why?
|
| Germ-Free Life | 1 | 2000 | 3 | 0.010 |
Why?
|
| Entamoeba histolytica | 1 | 2000 | 4 | 0.010 |
Why?
|
| Antigens, Protozoan | 1 | 2000 | 71 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4012 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1974 | 1 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1974 | 23 | 0.010 |
Why?
|
| Prokaryotic Cells | 1 | 1993 | 8 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 1974 | 36 | 0.010 |
Why?
|
| Fever | 1 | 1974 | 57 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 1993 | 32 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1974 | 217 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 25 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 64 | 0.010 |
Why?
|